Abstract
Introduction
The distribution of medical information over the Internet has grown exponentially in the past few years. The "information explosion" has fostered the proliferation of online journals, medical inform ation Web sites, and Web -based continuing educ ation program s.
Research has shown that more than 40 % of Intern et searches done by the general public relate to health care issues. The primary conc ern that Intern et users have is the quality of informat ion they find. The vastness of the number of Internet healthc are Web sites is confusing to patients, and they find it difficult to know which inform ation is accurate and worthwhile. As a result, the search for reliable medical information can be time-consumin g and frustrating.
Online publishing is also of benefit to physicians, who have traditionally been educated fro m textbooks that often are already years out of date when they are published.
The eMedicine site at www .emedicine.com offers free, up-to-date , peer-reviewed medic al information on otolaryngology, surgery, emergency medicine, pediatrics, neurology , sports medicine, physical medicine, ophthalmology, dermatology , and other topic s. The sites integrate photos, x-rays , video , and audio, adding a dimensio n to education that printed texts cannot offer.
Produc ing an electronic textbook present s several challenges. This article details some of the efforts that went into producing the eMedi cine site in general and eMedicine Otolaryngology-FPS in particular. It also explains the adva ntages of using an onl ine publi shin g system in which thousands of authors and editors around the world can simultaneously produce a curr ent, comprehensive, easily edited, and free resource for physicians and patient s. Table 1 outlines some of the advanta ges offered by the eMedicine textbo oks.
The rationale for online textbooks
Tr aditional medical textb ooks have several dra wback s. For example, textbooks require substantial time and effort to update . New editions of standard med ical textbooks can take from 2 to 5 year s to progre ss from concept to the book store. As a result, phy sician s almost invariably learn from and refer to textbooks that are years out of date. And, of co urse, medica l textbooks are expensive. Finally, the logisti cs of soliciting autho rs and monit oring the progre ss of manuscript s is cumbersom e and time-c onsuming.
As for patient s, before the proliferation of healthcare Web sites, they had limit ed access to the inform ation commonly used by physici ans and other healthcare professionals to make clinical decisions. Thi s lack of knowledge made it difficult for patients to unde rstand how clin icians think about clinica l problem s.
The eMedicine Web site is being developed to address some of these shortcomings . For example, despite the rigoro us review process, the content of eMedicine Otolaryn gology-Fl'S, as well as that of the other books in the series, can be assembled relativ ely quickly. These online books are designed for both the medic al community and the general public , and the Web site contains direct links to other medical information resources through Medline. Search functi ons have been designed to facilitate the diagnostic process. Users can type in symptoms, for o The potent antibacterial activity of CIPRO® * o The proven anti-inflammatory relief of hydrocortisone CIPRO' HC OTIC is indicated for acute otitis externa in adult and pediatric patients, 1 year and older, due to susceptible strains of P. aeruginosa, S. aureus, and P mirabilis. CIPRO' HC 011C is contraindicated in persons with a hypersensitivity to hydrocortisone or any quinolone, viral infections, and nonintact tympanic membranes. Most frequently reponed adver e events were headache (1.2%) and pruritus (0.4%). 
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The production process
Th e new paradi gm s of elec tronic publi shin g have strea mlined the process of soliciting manu scripts, ed iting and reviewing them , and eventually posting and distributing them. Th e patented , user-friendl y gro up publi shin g system (GPS) softw are makes the mechanical aspec t of writing eMedicine Otolaryngology-FPS ea sy. Otolaryngo log ists who might be interested in co ntributing to this book can learn mo re det ail s by logg ing o n to the www.emedicine.com page. Potenti al authors can view a list of topics and see which chapters are still ava ilable for ass ignment. Auth ors ca n then register online.
Chapters are formatted in one of three ways: as surg ical chapters, as medical chapters, and as ope n-format chapters. To assist authors in putting together a well-organized chapte r, all three format s are standardized and already inc lude relevant subhea dings such as etiology, differential diagnosis, surg ica l technique, and complica tio ns.
When an autho r has co mpleted a ch apter, he or she tran smi ts the electro nic file via e-m ail to a series of editors, all of whom ha ve been selected for their expertise in a particul ar area . A co py editor assists the author with the structure of the chapter and the use of software. A medi cal editor, who is typi cally ass igned to edit eight to 10 chapters, assists the author with style and conte nt issues. A section managing edito r reviews the ch apter to ensure
The eMedicine series repr esents a significant adva nce in the w ay medical information is distributed over the Internet. The numbers are impressive :
• 85 % of the editors are resid ency program directors, department chair s, or research directors,
• Each topi c is peer-revi ew ed by four physi cian s and a doctor of pharma cy.
• More than 6,000 academi c authors and editors are currently working on the proj ect. They repre sent almost 1,000 of the top medical schools, medical societi es, and medi cal institutions in the world, and they will contribute more than 250,000 hours to finishing this proj ect.
• Approximately 85 % of users are medical professionals,
• There are c urrently 2 million users per year, a figure that doubles every 6 months. The average duration of a user's visit to the site is 13 minute s. At the current rate, the site will register 40 million hits per year,
• eMedicine has won more than 30 national and intern ational awards.
exam ple, and recei ve a set of potential etiologies or a differential diagnosis. A built-in e-m ail featu re allows readers to communica te directl y with authors and editors . Rat Hepatocyte DNA Repair Assay MicronucleusTest (Mice) Dominant LethalTest (Mice) Long-term carcinogen icity studies in mice and rats have been com pleted for ciprofloxacin. After daily oral doses of 750mglkg (mice) and250 mglkg (rats) wereadministered for upto 2 years, therewas no evidence that ciprofloxacin had anycarcinogenicor tumorigenic effects in these species. No long term studiesof CIPRO' HC OTICsuspension have been performed to evaluate carcinogen ic potential. Fert ility studiesperforme d in rats at oral doses of ciprofloxacin up to 100mglkgl day revealed no evidence of impairme nt. Thi s would be over 1000 times the maximum recommended clinicaldose of ototopical ciprof loxacin based upon body surface area, assuming total absorption of ciprof loxacin from theear of a patienttreated with CIPRO' HCOTICtwice per day. Long term studieshave not beenperformed to evaluate thecarcinogenic potentialorthe effect on fertility of topical hydrocortisone. Mutagenicity studies with hydrocortisonewerenegative. Pregnancy: Teratogenic Effects. Pregnancy Category C: Reproduction studies have been performed in rats and mice usingoral doses of upto 100 mgl1<g and IV doses upto 30 mgl1<g and have revealed no evidence of harmto the fetus asa resul t of ciprofloxacin. In rabbit s, ciprofloxacin (30and100 mgl1<g orally)produced gastrointestinal disturbances resul ting in maternal weight loss and anincreased incidence of abortion, but no teratogenicitywas observed ateither dose. After intravenous administrationofdoses upto20 mgl 1<g, no maternal toxicity was produced in the rabbit, and no embryotoxicity or teratogenici ty was observed. Corticosteroids are generallyteratogenic in laboratory animals when administered systemically at relatively low dosage levels. The morepotent corticosteroids have been shown to beteratoge nic after dermal application in laboratory animals. Animal reprod uctionstudies have notbeenconducted wi thCIPRO' HCOTI C. Noadequate andwell controlled studies have been performed in pregnant women. Caution should be exercised when CIPRO' HCOTICis used by a pregnantwoman. Nursing Mothers: Ciprofloxacin is excreted in humanmilkwithsystemic use. It is not known whether ciprofloxacin is excreted in human milk followi ngtopi cal otic admi nistrat ion. Because of the potential for serious adverse reactions in nursing infants , a decision should be made whetherto discontinuenursing or to discontinuethe drug, taking intoaccount the importance of thedrugto the mother. Pediatric use: The safetyandefficacy of CIPRO' HC OTIChave beenestablished in pediatri c patients 2 years and older (131 pat ients) in adequate and well-controlled clinical trial s. Altho ugh nodataare available onpatients less thanage 2years,thereare no knownsafety concernsor differences in the disease process inthis popul ationwhich would preclude useof this product in pat ients one year and older. See DOSAGE AND AOMINISTRATION. ADVERSE REACTIONS In Phase 3 clinical trials, atotalof 564 patientsweretreated wi th CI PRO' HCOTIC. Adverse events withatleast remote relationship totreatment included headache(1.2%) and pruritus (0.4%) . The followi ng treatment-related adverse events were each reported in a single patient: mig rai ne, hypesthesia, paresthesia, fungal der matitis,cough, rash, urti caria, and alopecia. NDC0065-B531-10 CIPRO' is a registered trademark of Bayer AG. Li censed by Bayer AG Manuf actured by Bayer Corporation Rx Only U.S. Pat. Nos. 4,670,444; 4,844,902; 5,843,930; and Pat. Pending. Revised January, 1999 CHCOB-0199 
Plast ics
Online eMedicine has an exciting future. Some of the new technological features that it plans to introduce soon:
• An editing system tied to Microsoft Word, which will enable users to more easily edit copy .
• A system that automatically e-mails new articles in the literature to authors and editors.
• A system that keeps focused track of editorial revisions. When chapters are edited, this system will allow editors to concentrate on individual changes rather than rereading the entire chapter.
• A revolutionary new search engine. When a medical term is highlighted on the screen, the system will provide its definition in about one -half second , initiate a Medline search in 1 second, and automatically search 25 other medical sites that contain additional data such as x-rays, photographs, ECG tracings, etc.
• A system to allow the reader to be notified automatically whenever an eMedicine topic is updated.
• A system to globally check spelling and grammar in the entire databank of topics. This system will allow a small team of copy editors to maintain editorial quality over the long term.
stylistic con sistency in a given subspecialty area . Each chapter is also reviewed by a pharmacology editor and a continuing medical education editor. Finall y, the editor-in-chief, who is responsible for recruiting authors and editors, determines the overall structure of the text and oversee s the entire process. The finished produ ct is posted on the Web site only after it has been approved by everyone of these editors. Chapters can be updated at any time, and they can include sound as well as video clips and other graphics.
There are substantial production hurdl es and editorial, design , and coordination challenges. In order to remain current, chapters undergo continual mon itoring and revision . To maint ain high standards and con sistency of format, authors and editors must stay in continual communication. Fin ally , recruiting authors and editors who are recognized experts requires persistence.
The eMedicine site would not have been possible without the interactive GPS software used to produce and store electronic files and with out the per sisten ce of several visionary entrepreneurs . The GPS software was designed and dev eloped by Scott Plan z, MD; Jonathan Adler, MD ; Jo anne Berezin; and JeffBerezin. The startup and operating costs are substantial, but thanks to corporate spon sor ship , individual investment, and grant support, eMedicine Otolaryngolo gy-FPS and the other text s in the series are po sted on the Web and distributed to users without charge; and authors and editors are paid appropriately for their intellectual property. 
